As pharmaceutical manufacturers continue moving from paper-based records to digital documentation systems, artificial intelligence is increasingly entering the conversation. AI has clear potential to summarize logs, identify recurring deviations, support faster audit response, and help quality teams make sense of large volumes of GMP data. But the central message from Stephanie Wimberly (APTTMHY) and Piyush Modi (Amneal) in a recent Pharmaceutical Online
Twitter bio
(She/her) MA grad @CityUniLondon, former journalist at @chroniclelive, now with @gndrising.













